Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma

BACKGROUND: This phase 2 multi-institutional study was designed to determine whether gemcitabine (GEM) with fractionated stereotactic body radiotherapy (SBRT) results in acceptable late grade 2 to 4 gastrointestinal toxicity when compared with a prior trial of GEM with single-fraction SBRT in patien...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Herman, Joseph M, Chang, Daniel T, Goodman, Karyn A, Dholakia, Avani S, Raman, Siva P, Hacker-Prietz, Amy, Iacobuzio-Donahue, Christine A, Griffith, Mary E, Pawlik, Timothy M, Pai, Jonathan S, O'Reilly, Eileen, Fisher, George A, Wild, Aaron T, Rosati, Lauren M, Zheng, Lei, Wolfgang, Christopher L, Laheru, Daniel A, Columbo, Laurie A, Sugar, Elizabeth A, Koong, Albert C
Médium: Artigo
Jazyk:Inglês
Vydáno: BlackWell Publishing Ltd 2015
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4368473/
https://ncbi.nlm.nih.gov/pubmed/25538019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29161
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky